Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo–photothermal therapy
Source abstract
Abstract
Lanreotide (LT), a synthetic analog of somatostatin, has been demonstrated to specifically bind to somatostatin receptors (SSTRs), which are widely overexpressed in several types of cancer cells. In this study, we incorporated a chemotherapeutic agent, methotrexate (MTX), and a photosensitizer material, polyaniline (PANI), into hybrid polymer nanoparticles (NPs), which could target cancer cells after conjugation with LT (LT-MTX/PANI NPs). The successful preparation of LT-MTX/PANI NPs was confirmed by a small particle size (187.9 ± 3.2 nm), a polydispersity index of 0.232 ± 0.011, and a negative ζ potential of -14.6 ± 1.0 mV. Notably, LT-MTX/PANI NPs showed a greater uptake into SSTR-positive cancer cells and thereby better inhibited cell viability and induced higher levels of apoptosis than MTX, PANI NP, and MTX/PANI NP treatments did. In addition, the heat associated with the burst drug release induced by near-infrared (NIR) irradiation resulted in remarkably enhanced cell apoptosis, which was confirmed by an increase in the expression levels of apoptotic marker proteins. In agreement with the in vitro results, the administration of the SSTR-targeting NPs, followed by NIR exposure, to xenograft tumor-bearing mice resulted in an improved suppression of tumor development compared to that shown by MTX, PANI NPs, and MTX/PANI NPs, as well as by LT-MTX/PANI NPs without photothermal therapy. Thus, the SSTR-targeting NPs could be a promising delivery system for the effective treatment of SSTR-positive cancers. Statement of significance Somatostatin receptors are widely overexpressed in several types of cancer cells. In this study, we designed nanoparticles for targeted delivery of chemotherapeutic agents to tumor sites by conjugating hybrid polymers with a synthetic analog of somatostatin, specifically binding to somatostatin receptors. In addition, a photosensitizer material, polyaniline, was incorporated into the nanoparticles for combined chemo-photothermal therapy. The results demonstrated clear advantages of the newly designed targeted nanoparticles over their non-targeted counterparts or a free chemotherapeutic drug in inhibiting the viability of cancer cells in vitro and targeting/suppressing the tumor growth in an animal xenograft model. The study suggests that the designed nanoparticles are a promising delivery system for the effective treatment of somatostatin receptor-positive cancers.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Neuroendocrine Tumor Research Advances · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (66)
Show source-provided references
1. Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors10.3109/03639045.2016.1173052 ↗
2. Classification and nomenclature of somatostatin receptors10.1016/S0165-6147(00)88988-9 ↗
3. Q. Wang, R. Zhu, M. Wang, S. Xing, L. Li, Y. He, W. Cao, D. Gao, Targeted therapy of octreotide-modified oleanolic acid liposomes to somatostatin receptor overexpressing tumor cells, Nanomedicine (London, England) 12(8) (2017) 927–940.10.2217/nnm-2017-0009 ↗
4. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells10.3109/1061186X.2013.879386 ↗
5. Cytotoxic analog of somatostatin containing methotrexate inhibits growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice10.1016/0304-3835(92)90105-5 ↗
6. Targeting somatostatin receptors using in situ-bioconjugated fluorescent nanoparticles10.2217/nnm.12.42 ↗
7. Somatostatin receptors in the diagnosis and therapy of neuroendocrine tumors10.1634/theoncologist.2-1-50 ↗
8. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands10.1007/s002590100541 ↗
9. Somatostatin Receptor-Specific Analogs: Effects on Cell Proliferation and Growth Hormone Secretion in Human Somatotroph Tumors 1
10. Somatostatin receptor-targeted anti-cancer therapy10.2174/156720111793663633 ↗
11. Preparation, quality control and stability of 131I-Lanreotide10.1007/s10967-005-0902-7 ↗
12. Biochemical and functional properties of somatostatin receptors10.1111/j.1471-4159.1992.tb10938.x ↗
13. Electronic and vibrational spectra of novel Lanreotide peptide capped gold nanoparticles10.1016/j.saa.2011.07.050 ↗
14. Lanreotide-conjugated PEG-DSPE micelles: an efficient nanocarrier targeting to somatostatin receptor positive tumors10.3109/1061186X.2014.954118 ↗
15. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis10.1136/ard.60.8.729 ↗
16. Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction10.1002/bmc.1628 ↗
17. A conjugate of methotrexate and an analog of luteinizing hormone releasing hormone shows increased efficacy against prostate cancer10.1038/srep33894 ↗
18. Silver nanoparticle-embedded graphene oxide-methotrexate for targeted cancer treatment10.1016/j.colsurfb.2017.02.012 ↗
19. Easy on-demand self-assembly of lateral nanodimensional hybrid graphene oxide flakes for near-infrared-induced chemothermal therapy10.1038/am.2017.141 ↗
20. Combined phototherapy in anti-cancer treatment: therapeutics design and perspectives10.1007/s40005-016-0272-x ↗
21. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells10.1016/j.colsurfb.2016.03.045 ↗
22. Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma10.1021/acsami.5b06203 ↗
23. Combined photothermal and photodynamic therapy by hyaluronic acid-decorated polypyrrole nanoparticles10.2217/nnm-2016-0438 ↗
24. Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review10.1016/j.jconrel.2017.04.043 ↗
25. Rapamycin/DiR loaded lipid-polyaniline nanoparticles for dual-modal imaging guided enhanced photothermal and antiangiogenic combination therapy10.1016/j.jconrel.2016.07.005 ↗
26. A novel self-assembled sandwich nanomedicine for NIR-responsive release of NO10.1039/C5NR06630A ↗
27. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers10.1007/s11095-016-2007-0 ↗
28. Preparation of fluorescent polyaniline nanoparticles in aqueous solutions
29. Indocyanine Green-Loaded Silver Nanoparticle@Polyaniline Core/Shell Theranostic Nanocomposites for Photoacoustic/Near-Infrared Fluorescence Imaging-Guided and Single-Light-Triggered Photothermal and Photodynamic Therapy10.1021/acsami.6b11262 ↗
30. A strategy for photothermal conversion of polymeric nanoparticles by polyaniline for smart control of targeted drug delivery10.1088/1361-6528/aa645f ↗
31. Tissue engineering of electrically responsive tissues using polyaniline based polymers: a review10.1016/j.biomaterials.2014.07.020 ↗
32. Biocompatibility of electroactive polymers in tissues10.1002/1097-4636(20001205)52:3<467::AID-JBM4>3.0.CO;2-6 ↗
33. Electrical coupling of isolated cardiomyocyte clusters grown on aligned conductive nanofibrous meshes for their synchronized beating10.1016/j.biomaterials.2012.10.065 ↗
34. A critical review on the prospect of polyaniline-grafted biodegradable nanocomposite10.1016/j.cis.2017.08.006 ↗
35. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer10.1016/j.actbio.2017.01.015 ↗
36. Photothermal ablation of cancer cells using self-doped polyaniline nanoparticles10.1088/0957-4484/27/18/185104 ↗
37. Synthesis and characterization of polyaniline nanoparticles with enhanced microwave absorption10.1039/c3ra40973b ↗
38. Preparation of Polyaniline Nanoparticles in Micellar Solutions as Polymerization Medium10.1021/la9915320 ↗
39. The work function of doped polyaniline nanoparticles observed by Kelvin probe force microscopy10.1088/0957-4484/23/36/365705 ↗
40. Synthesis and characterization of multifunctional hybrid-polymeric nanoparticles for drug delivery and multimodal imaging of cancer10.2147/IJN.S86468 ↗
41. Nanoparticle-based combination drug delivery systems for synergistic cancer treatment10.1007/s40005-016-0252-1 ↗
42. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells10.2147/IJN.S24447 ↗
43. Targeted co-delivery of polypyrrole and rapamycin by trastuzumab-conjugated liposomes for combined chemo-photothermal therapy10.1016/j.ijpharm.2017.05.034 ↗
44. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors10.1021/mp200464x ↗
45. Development of oral self nano-emulsifying delivery system(s) of lanreotide with improved stability against presystemic thiol-disulfide exchange reactions10.1517/17425247.2016.1167034 ↗
46. Optimization and characterization of artesunate-loaded chitosan-decorated poly(D, L-lactide-co-glycolide) acid nanoparticles10.1155/2015/674175 ↗
47. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-d, l-lactide-co-glycolide (PLGA) nanoparticles10.1007/s12272-014-0424-3 ↗
48. Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer10.1021/acsami.5b10426 ↗
49. Simple and reliable HPLC method for the monitoring of methotrexate in osteosarcoma patients10.1093/chromsci/bmt081 ↗
50. Incorporation of chemotherapeutic agent and photosensitizer in a low temperature-sensitive liposome for effective chemo-hyperthermic anticancer activity10.1080/17425247.2017.1266330 ↗
51. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery
52. Progressive slowdown/prevention of cellular senescence by CD9-targeted delivery of rapamycin using lactose-wrapped calcium carbonate nanoparticles10.1038/srep43299 ↗
53. Development of Bioactive PEGylated Nanostructured Platforms for Sequential Delivery of Doxorubicin and Imatinib to Overcome Drug Resistance in Metastatic Tumors10.1021/acsami.6b09163 ↗
54. Increased mucosal production of granulocyte colony-stimulating factor is related to a delay in neutrophil apoptosis in Inflammatory Bowel disease10.1046/j.1440-1746.1999.01807.x ↗
55. Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors10.1016/j.actbio.2016.10.034 ↗
56. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers, Nanomedicine: Nanotechnology
57. F. ud Din, D.W. Kim, J.Y. Choi, R.K. Thapa, O. Mustapha, D.S. Kim, Y.-K. Oh, S.K. Ku, Y.S. Youn, K.T. Oh, Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration, Acta Biomater. 54 (2017) 239–248.10.1016/j.actbio.2017.03.007 ↗
58. Molecular origin of the self-assembly of lanreotide into nanotubes: a mutational approach10.1529/biophysj.107.108175 ↗
59. Composite Polylactic-Methacrylic Acid Copolymer Nanoparticles for the Delivery of Methotrexate10.1155/2012/579629 ↗
60. Polyaniline dispersions 2. UV—Vis absorption spectra10.1016/0379-6779(93)91266-5 ↗
61. Polyaniline nanofiber synthesis by co-use of ammonium peroxydisulfate and sodium hypochlorite10.1021/cm703678m ↗
62. Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells10.1186/1475-2867-6-5 ↗
63. The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells10.1038/aps.2009.59 ↗
64. NIR photothermal therapy using polyaniline nanoparticles10.1016/j.biomaterials.2013.08.075 ↗
65. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?10.1016/S0962-8924(02)00043-0 ↗
66. Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo10.1038/srep28983 ↗